Global coronavirus vaccine market is expected to grow at a robust rate in value terms to reach USD91325.46 million by the end of 2021. Coronaviruses are a group of viruses belonging to the coronaviridae family that can affect both mammals and birds. The common symptoms include mild illness such as common cold, respiratory tract infections, among others.

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from the saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. The first case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 23rd May 2021, coronavirus has affected more than 200 countries with the total number of coronavirus cases reaching 168,032,098 out of which 149,371,973 have recovered and around 3,488,577 people have succumbed to the disease.

Global coronavirus vaccine market is expected to grow at a robust rate during the forecast period. The global coronavirus vaccine market is driven by the increasing prevalence of this disease across different parts of the globe. This has increased the need to protect the world from the virus, thereby increased sales of coronavirus vaccine through 2026. Furthermore, increasing research and development activities by various pharmaceutical & biotechnology players for the development of potential vaccines is anticipated to foster the market growth. According to WHO, there are more than 70 coronavirus vaccines under development by different companies and organizations.

Currently, mRNA-based vaccine named Moderna COVID-19 Vaccine (mRNA-1273), adenovirus-based vaccine named COVID-19 Vaccine AstraZeneca (AZD1222) also known as Covishield in India and Sputnik V which constitutes recombinant adenovirus vaccine which is developed by Gamaleya Research Institute, Russia are being used for vaccination among adults. The vaccine developed by Moderna, Inc., Pfizer Inc., AstraZeneca PLC are leading the race and is currently administered to entire population. T-COVIDTM, AdCOVID and COVI-VAC are intranasal COVID-19 vaccines which are under pre-clinical and phase 1 trials.

The global coronavirus vaccine market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end user, company, and region. Based on infection type, the market can be categorized into SARS-CoV-2, SARS-CoV and MERS-CoV. The SARS-CoV-2 segment is expected to dominate the market since this infection or virus is the primary cause of the pandemic.

Regionally, the global coronavirus vaccine market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, Asia-Pacific is expected to witness significant growth during the forecast period in the overall coronavirus vaccine market.

Major players operating in the global coronavirus vaccine market include Moderna, Inc., Johnson & Johnson SA, Pfizer Inc., Sinopharm Group Company Ltd., AstraZeneca PLC, are the leading companies and Serum Institute of India Pvt Ltd., Bharat Biotech International Ltd., Sinovac Biotech Ltd., Sanofi SA, GlaxoSmithKline PLC, Novavax, Inc., Airway Therapeutics, Inc., Cadila Healthcare Ltd., CanSino Biologics Inc., Mitsubishi Chemical Holdings Corporation, Eubiologics Co. Ltd., United Biomedical Inc., Merck & Co., Inc., CureVac N.V., Inovio Pharmaceuticals, Inc. among others. The companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and estimate the market size of global coronavirus vaccine market from 2021 to 2026.
  • To estimate and forecast the market size of global coronavirus vaccine market from 2022 to 2026 and growth rate until 2026.
  • To classify and forecast global coronavirus vaccine market based on infection type, vaccine type, product type, route of administration, patient type, end user, company, and regional distribution.
  • To identify dominant region or segment in the global coronavirus vaccine market.
  • To identify drivers and challenges for global coronavirus vaccine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus vaccine market.
  • To conduct pricing analysis for global coronavirus vaccine market.
  • To identify and analyze the profile of leading players operating in global coronavirus vaccine market.
  • To identify key sustainable strategies adopted by market players in global coronavirus vaccine market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global coronavirus vaccine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Coronavirus vaccine manufacturers, suppliers, distributors, and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to coronavirus vaccine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Coronavirus Vaccine Market, By Infection Type:
    • SARS-CoV-2
    • SARS-CoV
    • MERS-CoV
  • Global Coronavirus Vaccine Market, By Vaccine Type:
    • Virus Vaccine
    • Viral Vector Vaccine
    • Nucleic Acid Vaccine
    • Protein Based Vaccine
    • Others
  • Global Coronavirus Vaccine Market, By Product Type:
    • Monovalent Vaccine
    • Multivariant Vaccine
  • Global Coronavirus Vaccine Market, By Route of Administration:
    • Intramuscular
    • Oral
    • Intranasal
  • Global Coronavirus Vaccine Market, By Patient Type:
    • Adult
    • Pediatric
  • Global Coronavirus Vaccine Market, By End User:
    • Hospitals
    • Clinics
    • Research Institutes
    • Others
  • Global Coronavirus Vaccine Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Singapore
      • Japan
      • South Korea
      • Hong Kong
      • Australia
      • Thailand
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Kuwait
      • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Coronavirus Vaccine Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Vaccine Efficacy

5.3.  Patient Satisfaction Analysis

5.4.  Post-Vaccination Side Effects

6.    Global Coronavirus Vaccine Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value and By Volume

6.2.  Market Share & Forecast

6.2.1.     By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)

6.2.2.     By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine, Others)

6.2.3.     By Product Type (Monovalent Vaccine v/s Multivariant Vaccine)

6.2.4.     By Route of Administration (Intramuscular, Oral, Intranasal)

6.2.5.     By Patient Type (Adult v/s Pediatric)

6.2.6.     By End User (Hospitals, Clinics, Research Institutes, Others)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Market Map

7.    North America Coronavirus Vaccine Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Infection Type

7.2.2.     By Vaccine Type

7.2.3.     By Product Type

7.2.4.     By Route of Administration

7.2.5.     By Patient Type

7.2.6.     By End User

7.2.7.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Coronavirus Vaccine Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Infection Type

7.3.1.2.2.             By Vaccine Type

7.3.1.2.3.             By Product Type

7.3.1.2.4.             By Route of Administration

7.3.1.2.5.             By Patient Type

7.3.1.2.6.             By End User

7.3.2.     Mexico Coronavirus Vaccine Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Infection Type

7.3.2.2.2.             By Vaccine Type

7.3.2.2.3.             By Product Type

7.3.2.2.4.             By Route of Administration

7.3.2.2.5.             By Patient Type

7.3.2.2.6.             By End User

7.3.3.     Canada Coronavirus Vaccine Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Infection Type

7.3.3.2.2.             By Vaccine Type

7.3.3.2.3.             By Product Type

7.3.3.2.4.             By Route of Administration

7.3.3.2.5.             By Patient Type

7.3.3.2.6.             By End User

8.    Europe Coronavirus Vaccine Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Infection Type

8.2.2.     By Vaccine Type

8.2.3.     By Product Type

8.2.4.     By Route of Administration

8.2.5.     By Patient Type

8.2.6.     By End User

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     United Kingdom Coronavirus Vaccine Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Infection Type

8.3.1.2.2.             By Vaccine Type

8.3.1.2.3.             By Product Type

8.3.1.2.4.             By Route of Administration

8.3.1.2.5.             By Patient Type

8.3.1.2.6.             By End User

8.3.2.     Germany Coronavirus Vaccine Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Infection Type

8.3.2.2.2.             By Vaccine Type

8.3.2.2.3.             By Product Type

8.3.2.2.4.             By Route of Administration

8.3.2.2.5.             By Patient Type

8.3.2.2.6.             By End User

8.3.3.     France Coronavirus Vaccine Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Infection Type

8.3.3.2.2.             By Vaccine Type

8.3.3.2.3.             By Product Type

8.3.3.2.4.             By Route of Administration

8.3.3.2.5.             By Patient Type

8.3.3.2.6.             By End User

8.3.4.     Italy Coronavirus Vaccine Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Infection Type

8.3.4.2.2.             By Vaccine Type

8.3.4.2.3.             By Product Type

8.3.4.2.4.             By Route of Administration

8.3.4.2.5.             By Patient Type

8.3.4.2.6.             By End User

8.3.5.     Spain Coronavirus Vaccine Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Infection Type

8.3.5.2.2.             By Vaccine Type

8.3.5.2.3.             By Product Type

8.3.5.2.4.             By Route of Administration

8.3.5.2.5.             By Patient Type

8.3.5.2.6.             By End User

9.    Asia-Pacific Coronavirus Vaccine Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Infection Type

9.2.2.     By Vaccine Type

9.2.3.     By Product Type

9.2.4.     By Route of Administration

9.2.5.     By Patient Type

9.2.6.     By End User

9.2.7.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Coronavirus Vaccine Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Infection Type

9.3.1.2.2.             By Vaccine Type

9.3.1.2.3.             By Product Type

9.3.1.2.4.             By Route of Administration

9.3.1.2.5.             By Patient Type

9.3.1.2.6.             By End User

9.3.2.     India Coronavirus Vaccine Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Infection Type

9.3.2.2.2.             By Vaccine Type

9.3.2.2.3.             By Product Type

9.3.2.2.4.             By Route of Administration

9.3.2.2.5.             By Patient Type

9.3.2.2.6.             By End User

9.3.3.     Singapore Coronavirus Vaccine Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast